nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—CYP2D6—breast cancer	0.199	0.538	CbGaD
Ranolazine—CYP3A4—breast cancer	0.17	0.462	CbGaD
Ranolazine—CYP3A4—Exemestane—breast cancer	0.0391	0.103	CbGbCtD
Ranolazine—CYP2D6—Idarubicin—breast cancer	0.0353	0.093	CbGbCtD
Ranolazine—CYP3A4—Letrozole—breast cancer	0.0333	0.0876	CbGbCtD
Ranolazine—CYP3A4—Anastrozole—breast cancer	0.0297	0.0781	CbGbCtD
Ranolazine—CYP3A4—Toremifene—breast cancer	0.0271	0.0714	CbGbCtD
Ranolazine—CYP3A4—Fulvestrant—breast cancer	0.0252	0.0664	CbGbCtD
Ranolazine—CYP3A4—Thiotepa—breast cancer	0.0225	0.0592	CbGbCtD
Ranolazine—CYP3A4—Ixabepilone—breast cancer	0.0206	0.0541	CbGbCtD
Ranolazine—CYP3A4—Lapatinib—breast cancer	0.0198	0.0521	CbGbCtD
Ranolazine—CYP2D6—Vinorelbine—breast cancer	0.0173	0.0454	CbGbCtD
Ranolazine—CYP2D6—Tamoxifen—breast cancer	0.0156	0.041	CbGbCtD
Ranolazine—CYP3A4—Raloxifene—breast cancer	0.015	0.0395	CbGbCtD
Ranolazine—CYP3A4—Vinorelbine—breast cancer	0.011	0.0289	CbGbCtD
Ranolazine—CYP2D6—Vinblastine—breast cancer	0.0106	0.028	CbGbCtD
Ranolazine—CYP3A4—Tamoxifen—breast cancer	0.00991	0.0261	CbGbCtD
Ranolazine—CYP3A4—Mitoxantrone—breast cancer	0.00966	0.0254	CbGbCtD
Ranolazine—CYP3A4—Paclitaxel—breast cancer	0.00771	0.0203	CbGbCtD
Ranolazine—CYP3A4—Irinotecan—breast cancer	0.00761	0.02	CbGbCtD
Ranolazine—CYP3A4—Vinblastine—breast cancer	0.00676	0.0178	CbGbCtD
Ranolazine—CYP2D6—Doxorubicin—breast cancer	0.00654	0.0172	CbGbCtD
Ranolazine—CYP3A4—Docetaxel—breast cancer	0.00557	0.0147	CbGbCtD
Ranolazine—CYP3A4—Doxorubicin—breast cancer	0.00416	0.0109	CbGbCtD
Ranolazine—Bupivacaine—PTGER1—breast cancer	0.00148	0.269	CrCbGaD
Ranolazine—Levobupivacaine—SCN10A—breast cancer	0.000695	0.127	CrCbGaD
Ranolazine—Carvedilol—HIF1A—breast cancer	0.000594	0.108	CrCbGaD
Ranolazine—Bupivacaine—SCN10A—breast cancer	0.000556	0.101	CrCbGaD
Ranolazine—Ropivacaine—SCN10A—breast cancer	0.000448	0.0817	CrCbGaD
Ranolazine—Carvedilol—VEGFA—breast cancer	0.000239	0.0436	CrCbGaD
Ranolazine—Levobupivacaine—CYP3A4—breast cancer	0.000183	0.0334	CrCbGaD
Ranolazine—Bupivacaine—CYP2D6—breast cancer	0.000171	0.0311	CrCbGaD
Ranolazine—Bupivacaine—CYP3A4—breast cancer	0.000147	0.0267	CrCbGaD
Ranolazine—Ropivacaine—CYP2D6—breast cancer	0.000138	0.0251	CrCbGaD
Ranolazine—Carvedilol—PTGS1—breast cancer	0.000126	0.023	CrCbGaD
Ranolazine—Ropivacaine—CYP3A4—breast cancer	0.000118	0.0215	CrCbGaD
Ranolazine—Carvedilol—CYP1A1—breast cancer	0.000115	0.0211	CrCbGaD
Ranolazine—Propranolol—CYP1A1—breast cancer	8.78e-05	0.016	CrCbGaD
Ranolazine—Carvedilol—CYP2D6—breast cancer	8.59e-05	0.0157	CrCbGaD
Ranolazine—Carvedilol—CYP3A4—breast cancer	7.37e-05	0.0134	CrCbGaD
Ranolazine—Epistaxis—Epirubicin—breast cancer	6.83e-05	0.000352	CcSEcCtD
Ranolazine—Pruritus—Gemcitabine—breast cancer	6.83e-05	0.000352	CcSEcCtD
Ranolazine—Nausea—Thiotepa—breast cancer	6.82e-05	0.000351	CcSEcCtD
Ranolazine—Urethral disorder—Methotrexate—breast cancer	6.81e-05	0.000351	CcSEcCtD
Ranolazine—Weight decreased—Doxorubicin—breast cancer	6.8e-05	0.00035	CcSEcCtD
Ranolazine—Dry mouth—Capecitabine—breast cancer	6.77e-05	0.000348	CcSEcCtD
Ranolazine—Shock—Docetaxel—breast cancer	6.74e-05	0.000347	CcSEcCtD
Ranolazine—Nervous system disorder—Docetaxel—breast cancer	6.72e-05	0.000346	CcSEcCtD
Ranolazine—Pruritus—Fluorouracil—breast cancer	6.72e-05	0.000346	CcSEcCtD
Ranolazine—Thrombocytopenia—Docetaxel—breast cancer	6.71e-05	0.000345	CcSEcCtD
Ranolazine—Visual impairment—Methotrexate—breast cancer	6.7e-05	0.000345	CcSEcCtD
Ranolazine—Confusional state—Capecitabine—breast cancer	6.69e-05	0.000344	CcSEcCtD
Ranolazine—Feeling abnormal—Paclitaxel—breast cancer	6.66e-05	0.000343	CcSEcCtD
Ranolazine—Skin disorder—Docetaxel—breast cancer	6.65e-05	0.000342	CcSEcCtD
Ranolazine—Bradycardia—Epirubicin—breast cancer	6.62e-05	0.000341	CcSEcCtD
Ranolazine—Gastrointestinal pain—Paclitaxel—breast cancer	6.61e-05	0.00034	CcSEcCtD
Ranolazine—Renal failure—Doxorubicin—breast cancer	6.59e-05	0.000339	CcSEcCtD
Ranolazine—Dizziness—Irinotecan—breast cancer	6.55e-05	0.000337	CcSEcCtD
Ranolazine—Propranolol—CYP2D6—breast cancer	6.54e-05	0.0119	CrCbGaD
Ranolazine—Anorexia—Docetaxel—breast cancer	6.53e-05	0.000336	CcSEcCtD
Ranolazine—Shock—Capecitabine—breast cancer	6.53e-05	0.000336	CcSEcCtD
Ranolazine—Nervous system disorder—Capecitabine—breast cancer	6.5e-05	0.000335	CcSEcCtD
Ranolazine—Eye disorder—Methotrexate—breast cancer	6.49e-05	0.000334	CcSEcCtD
Ranolazine—Thrombocytopenia—Capecitabine—breast cancer	6.49e-05	0.000334	CcSEcCtD
Ranolazine—Tinnitus—Methotrexate—breast cancer	6.48e-05	0.000334	CcSEcCtD
Ranolazine—Hypoaesthesia—Epirubicin—breast cancer	6.47e-05	0.000333	CcSEcCtD
Ranolazine—Cardiac disorder—Methotrexate—breast cancer	6.45e-05	0.000332	CcSEcCtD
Ranolazine—Skin disorder—Capecitabine—breast cancer	6.44e-05	0.000332	CcSEcCtD
Ranolazine—Urinary tract disorder—Epirubicin—breast cancer	6.42e-05	0.000331	CcSEcCtD
Ranolazine—Urticaria—Paclitaxel—breast cancer	6.42e-05	0.00033	CcSEcCtD
Ranolazine—Hyperhidrosis—Capecitabine—breast cancer	6.41e-05	0.00033	CcSEcCtD
Ranolazine—Oedema peripheral—Epirubicin—breast cancer	6.41e-05	0.00033	CcSEcCtD
Ranolazine—Hypotension—Docetaxel—breast cancer	6.4e-05	0.000329	CcSEcCtD
Ranolazine—Haematuria—Doxorubicin—breast cancer	6.39e-05	0.000329	CcSEcCtD
Ranolazine—Connective tissue disorder—Epirubicin—breast cancer	6.39e-05	0.000329	CcSEcCtD
Ranolazine—Abdominal pain—Paclitaxel—breast cancer	6.39e-05	0.000329	CcSEcCtD
Ranolazine—Urethral disorder—Epirubicin—breast cancer	6.38e-05	0.000328	CcSEcCtD
Ranolazine—Epistaxis—Doxorubicin—breast cancer	6.32e-05	0.000325	CcSEcCtD
Ranolazine—Anorexia—Capecitabine—breast cancer	6.32e-05	0.000325	CcSEcCtD
Ranolazine—Angiopathy—Methotrexate—breast cancer	6.31e-05	0.000325	CcSEcCtD
Ranolazine—Vomiting—Mitoxantrone—breast cancer	6.3e-05	0.000324	CcSEcCtD
Ranolazine—Vomiting—Irinotecan—breast cancer	6.3e-05	0.000324	CcSEcCtD
Ranolazine—Dizziness—Fluorouracil—breast cancer	6.28e-05	0.000323	CcSEcCtD
Ranolazine—Visual impairment—Epirubicin—breast cancer	6.27e-05	0.000323	CcSEcCtD
Ranolazine—Mediastinal disorder—Methotrexate—breast cancer	6.26e-05	0.000322	CcSEcCtD
Ranolazine—Rash—Mitoxantrone—breast cancer	6.25e-05	0.000322	CcSEcCtD
Ranolazine—Rash—Irinotecan—breast cancer	6.25e-05	0.000322	CcSEcCtD
Ranolazine—Dermatitis—Irinotecan—breast cancer	6.24e-05	0.000321	CcSEcCtD
Ranolazine—Dermatitis—Mitoxantrone—breast cancer	6.24e-05	0.000321	CcSEcCtD
Ranolazine—Headache—Mitoxantrone—breast cancer	6.21e-05	0.00032	CcSEcCtD
Ranolazine—Headache—Irinotecan—breast cancer	6.21e-05	0.00032	CcSEcCtD
Ranolazine—Hypotension—Capecitabine—breast cancer	6.2e-05	0.000319	CcSEcCtD
Ranolazine—Insomnia—Docetaxel—breast cancer	6.2e-05	0.000319	CcSEcCtD
Ranolazine—Paraesthesia—Docetaxel—breast cancer	6.15e-05	0.000317	CcSEcCtD
Ranolazine—Vomiting—Gemcitabine—breast cancer	6.14e-05	0.000316	CcSEcCtD
Ranolazine—Carvedilol—ABCB1—breast cancer	6.14e-05	0.0112	CrCbGaD
Ranolazine—Bradycardia—Doxorubicin—breast cancer	6.13e-05	0.000315	CcSEcCtD
Ranolazine—Dyspnoea—Docetaxel—breast cancer	6.11e-05	0.000314	CcSEcCtD
Ranolazine—Somnolence—Docetaxel—breast cancer	6.09e-05	0.000313	CcSEcCtD
Ranolazine—Mental disorder—Methotrexate—breast cancer	6.09e-05	0.000313	CcSEcCtD
Ranolazine—Rash—Gemcitabine—breast cancer	6.09e-05	0.000313	CcSEcCtD
Ranolazine—Dermatitis—Gemcitabine—breast cancer	6.08e-05	0.000313	CcSEcCtD
Ranolazine—Eye disorder—Epirubicin—breast cancer	6.08e-05	0.000313	CcSEcCtD
Ranolazine—Tinnitus—Epirubicin—breast cancer	6.06e-05	0.000312	CcSEcCtD
Ranolazine—Malnutrition—Methotrexate—breast cancer	6.05e-05	0.000311	CcSEcCtD
Ranolazine—Headache—Gemcitabine—breast cancer	6.05e-05	0.000311	CcSEcCtD
Ranolazine—Cardiac disorder—Epirubicin—breast cancer	6.04e-05	0.000311	CcSEcCtD
Ranolazine—Vomiting—Fluorouracil—breast cancer	6.03e-05	0.000311	CcSEcCtD
Ranolazine—Dyspepsia—Docetaxel—breast cancer	6.03e-05	0.00031	CcSEcCtD
Ranolazine—Insomnia—Capecitabine—breast cancer	6e-05	0.000309	CcSEcCtD
Ranolazine—Hypoaesthesia—Doxorubicin—breast cancer	5.99e-05	0.000308	CcSEcCtD
Ranolazine—Rash—Fluorouracil—breast cancer	5.98e-05	0.000308	CcSEcCtD
Ranolazine—Dermatitis—Fluorouracil—breast cancer	5.98e-05	0.000308	CcSEcCtD
Ranolazine—Paraesthesia—Capecitabine—breast cancer	5.96e-05	0.000307	CcSEcCtD
Ranolazine—Decreased appetite—Docetaxel—breast cancer	5.96e-05	0.000307	CcSEcCtD
Ranolazine—Headache—Fluorouracil—breast cancer	5.95e-05	0.000306	CcSEcCtD
Ranolazine—Urinary tract disorder—Doxorubicin—breast cancer	5.94e-05	0.000306	CcSEcCtD
Ranolazine—Oedema peripheral—Doxorubicin—breast cancer	5.93e-05	0.000305	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Docetaxel—breast cancer	5.91e-05	0.000304	CcSEcCtD
Ranolazine—Connective tissue disorder—Doxorubicin—breast cancer	5.91e-05	0.000304	CcSEcCtD
Ranolazine—Dyspnoea—Capecitabine—breast cancer	5.91e-05	0.000304	CcSEcCtD
Ranolazine—Fatigue—Docetaxel—breast cancer	5.91e-05	0.000304	CcSEcCtD
Ranolazine—Angiopathy—Epirubicin—breast cancer	5.9e-05	0.000304	CcSEcCtD
Ranolazine—Urethral disorder—Doxorubicin—breast cancer	5.9e-05	0.000304	CcSEcCtD
Ranolazine—Nausea—Irinotecan—breast cancer	5.89e-05	0.000303	CcSEcCtD
Ranolazine—Nausea—Mitoxantrone—breast cancer	5.89e-05	0.000303	CcSEcCtD
Ranolazine—Mediastinal disorder—Epirubicin—breast cancer	5.86e-05	0.000302	CcSEcCtD
Ranolazine—Constipation—Docetaxel—breast cancer	5.86e-05	0.000302	CcSEcCtD
Ranolazine—Dyspepsia—Capecitabine—breast cancer	5.84e-05	0.000301	CcSEcCtD
Ranolazine—Arrhythmia—Epirubicin—breast cancer	5.81e-05	0.000299	CcSEcCtD
Ranolazine—Visual impairment—Doxorubicin—breast cancer	5.8e-05	0.000298	CcSEcCtD
Ranolazine—Asthenia—Paclitaxel—breast cancer	5.8e-05	0.000298	CcSEcCtD
Ranolazine—Decreased appetite—Capecitabine—breast cancer	5.77e-05	0.000297	CcSEcCtD
Ranolazine—Nausea—Gemcitabine—breast cancer	5.73e-05	0.000295	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Capecitabine—breast cancer	5.73e-05	0.000295	CcSEcCtD
Ranolazine—Fatigue—Capecitabine—breast cancer	5.72e-05	0.000294	CcSEcCtD
Ranolazine—Pruritus—Paclitaxel—breast cancer	5.72e-05	0.000294	CcSEcCtD
Ranolazine—Vision blurred—Methotrexate—breast cancer	5.7e-05	0.000293	CcSEcCtD
Ranolazine—Mental disorder—Epirubicin—breast cancer	5.7e-05	0.000293	CcSEcCtD
Ranolazine—Constipation—Capecitabine—breast cancer	5.67e-05	0.000292	CcSEcCtD
Ranolazine—Malnutrition—Epirubicin—breast cancer	5.66e-05	0.000291	CcSEcCtD
Ranolazine—Feeling abnormal—Docetaxel—breast cancer	5.65e-05	0.000291	CcSEcCtD
Ranolazine—Nausea—Fluorouracil—breast cancer	5.64e-05	0.00029	CcSEcCtD
Ranolazine—Eye disorder—Doxorubicin—breast cancer	5.62e-05	0.000289	CcSEcCtD
Ranolazine—Tinnitus—Doxorubicin—breast cancer	5.61e-05	0.000289	CcSEcCtD
Ranolazine—Propranolol—CYP3A4—breast cancer	5.61e-05	0.0102	CrCbGaD
Ranolazine—Gastrointestinal pain—Docetaxel—breast cancer	5.6e-05	0.000288	CcSEcCtD
Ranolazine—Cardiac disorder—Doxorubicin—breast cancer	5.59e-05	0.000287	CcSEcCtD
Ranolazine—Flatulence—Epirubicin—breast cancer	5.58e-05	0.000287	CcSEcCtD
Ranolazine—Feeling abnormal—Capecitabine—breast cancer	5.47e-05	0.000281	CcSEcCtD
Ranolazine—Angiopathy—Doxorubicin—breast cancer	5.46e-05	0.000281	CcSEcCtD
Ranolazine—Muscle spasms—Epirubicin—breast cancer	5.44e-05	0.00028	CcSEcCtD
Ranolazine—Vertigo—Methotrexate—breast cancer	5.44e-05	0.00028	CcSEcCtD
Ranolazine—Gastrointestinal pain—Capecitabine—breast cancer	5.42e-05	0.000279	CcSEcCtD
Ranolazine—Mediastinal disorder—Doxorubicin—breast cancer	5.42e-05	0.000279	CcSEcCtD
Ranolazine—Abdominal pain—Docetaxel—breast cancer	5.42e-05	0.000279	CcSEcCtD
Ranolazine—Leukopenia—Methotrexate—breast cancer	5.42e-05	0.000279	CcSEcCtD
Ranolazine—Arrhythmia—Doxorubicin—breast cancer	5.38e-05	0.000277	CcSEcCtD
Ranolazine—Dizziness—Paclitaxel—breast cancer	5.34e-05	0.000275	CcSEcCtD
Ranolazine—Vision blurred—Epirubicin—breast cancer	5.34e-05	0.000275	CcSEcCtD
Ranolazine—Cough—Methotrexate—breast cancer	5.28e-05	0.000272	CcSEcCtD
Ranolazine—Mental disorder—Doxorubicin—breast cancer	5.27e-05	0.000271	CcSEcCtD
Ranolazine—Urticaria—Capecitabine—breast cancer	5.27e-05	0.000271	CcSEcCtD
Ranolazine—Abdominal pain—Capecitabine—breast cancer	5.24e-05	0.00027	CcSEcCtD
Ranolazine—Malnutrition—Doxorubicin—breast cancer	5.24e-05	0.00027	CcSEcCtD
Ranolazine—Flatulence—Doxorubicin—breast cancer	5.16e-05	0.000266	CcSEcCtD
Ranolazine—Vomiting—Paclitaxel—breast cancer	5.14e-05	0.000264	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.12e-05	0.000263	CcSEcCtD
Ranolazine—Rash—Paclitaxel—breast cancer	5.1e-05	0.000262	CcSEcCtD
Ranolazine—Dermatitis—Paclitaxel—breast cancer	5.09e-05	0.000262	CcSEcCtD
Ranolazine—Vertigo—Epirubicin—breast cancer	5.09e-05	0.000262	CcSEcCtD
Ranolazine—Syncope—Epirubicin—breast cancer	5.08e-05	0.000261	CcSEcCtD
Ranolazine—Leukopenia—Epirubicin—breast cancer	5.07e-05	0.000261	CcSEcCtD
Ranolazine—Headache—Paclitaxel—breast cancer	5.06e-05	0.000261	CcSEcCtD
Ranolazine—Muscle spasms—Doxorubicin—breast cancer	5.04e-05	0.000259	CcSEcCtD
Ranolazine—Palpitations—Epirubicin—breast cancer	5e-05	0.000258	CcSEcCtD
Ranolazine—Confusional state—Methotrexate—breast cancer	4.98e-05	0.000256	CcSEcCtD
Ranolazine—Loss of consciousness—Epirubicin—breast cancer	4.98e-05	0.000256	CcSEcCtD
Ranolazine—Cough—Epirubicin—breast cancer	4.94e-05	0.000254	CcSEcCtD
Ranolazine—Vision blurred—Doxorubicin—breast cancer	4.94e-05	0.000254	CcSEcCtD
Ranolazine—Asthenia—Docetaxel—breast cancer	4.92e-05	0.000253	CcSEcCtD
Ranolazine—Pruritus—Docetaxel—breast cancer	4.85e-05	0.000249	CcSEcCtD
Ranolazine—Nervous system disorder—Methotrexate—breast cancer	4.84e-05	0.000249	CcSEcCtD
Ranolazine—Thrombocytopenia—Methotrexate—breast cancer	4.83e-05	0.000249	CcSEcCtD
Ranolazine—Anxiety—Epirubicin—breast cancer	4.8e-05	0.000247	CcSEcCtD
Ranolazine—Nausea—Paclitaxel—breast cancer	4.8e-05	0.000247	CcSEcCtD
Ranolazine—Skin disorder—Methotrexate—breast cancer	4.8e-05	0.000247	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.79e-05	0.000246	CcSEcCtD
Ranolazine—Hyperhidrosis—Methotrexate—breast cancer	4.77e-05	0.000246	CcSEcCtD
Ranolazine—Asthenia—Capecitabine—breast cancer	4.76e-05	0.000245	CcSEcCtD
Ranolazine—Dry mouth—Epirubicin—breast cancer	4.71e-05	0.000243	CcSEcCtD
Ranolazine—Vertigo—Doxorubicin—breast cancer	4.71e-05	0.000242	CcSEcCtD
Ranolazine—Anorexia—Methotrexate—breast cancer	4.71e-05	0.000242	CcSEcCtD
Ranolazine—Syncope—Doxorubicin—breast cancer	4.7e-05	0.000242	CcSEcCtD
Ranolazine—Pruritus—Capecitabine—breast cancer	4.69e-05	0.000242	CcSEcCtD
Ranolazine—Leukopenia—Doxorubicin—breast cancer	4.69e-05	0.000241	CcSEcCtD
Ranolazine—Propranolol—ABCB1—breast cancer	4.67e-05	0.00851	CrCbGaD
Ranolazine—Confusional state—Epirubicin—breast cancer	4.66e-05	0.00024	CcSEcCtD
Ranolazine—Palpitations—Doxorubicin—breast cancer	4.63e-05	0.000238	CcSEcCtD
Ranolazine—Hypotension—Methotrexate—breast cancer	4.61e-05	0.000237	CcSEcCtD
Ranolazine—Loss of consciousness—Doxorubicin—breast cancer	4.6e-05	0.000237	CcSEcCtD
Ranolazine—Cough—Doxorubicin—breast cancer	4.57e-05	0.000235	CcSEcCtD
Ranolazine—Shock—Epirubicin—breast cancer	4.55e-05	0.000234	CcSEcCtD
Ranolazine—Nervous system disorder—Epirubicin—breast cancer	4.53e-05	0.000233	CcSEcCtD
Ranolazine—Dizziness—Docetaxel—breast cancer	4.53e-05	0.000233	CcSEcCtD
Ranolazine—Thrombocytopenia—Epirubicin—breast cancer	4.52e-05	0.000233	CcSEcCtD
Ranolazine—Skin disorder—Epirubicin—breast cancer	4.49e-05	0.000231	CcSEcCtD
Ranolazine—Hyperhidrosis—Epirubicin—breast cancer	4.47e-05	0.00023	CcSEcCtD
Ranolazine—Insomnia—Methotrexate—breast cancer	4.47e-05	0.00023	CcSEcCtD
Ranolazine—Anxiety—Doxorubicin—breast cancer	4.44e-05	0.000229	CcSEcCtD
Ranolazine—Paraesthesia—Methotrexate—breast cancer	4.43e-05	0.000228	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.43e-05	0.000228	CcSEcCtD
Ranolazine—Anorexia—Epirubicin—breast cancer	4.4e-05	0.000227	CcSEcCtD
Ranolazine—Dyspnoea—Methotrexate—breast cancer	4.4e-05	0.000227	CcSEcCtD
Ranolazine—Somnolence—Methotrexate—breast cancer	4.39e-05	0.000226	CcSEcCtD
Ranolazine—Dizziness—Capecitabine—breast cancer	4.39e-05	0.000226	CcSEcCtD
Ranolazine—Dry mouth—Doxorubicin—breast cancer	4.36e-05	0.000225	CcSEcCtD
Ranolazine—Vomiting—Docetaxel—breast cancer	4.36e-05	0.000224	CcSEcCtD
Ranolazine—Dyspepsia—Methotrexate—breast cancer	4.35e-05	0.000224	CcSEcCtD
Ranolazine—Rash—Docetaxel—breast cancer	4.32e-05	0.000222	CcSEcCtD
Ranolazine—Hypotension—Epirubicin—breast cancer	4.32e-05	0.000222	CcSEcCtD
Ranolazine—Dermatitis—Docetaxel—breast cancer	4.32e-05	0.000222	CcSEcCtD
Ranolazine—Confusional state—Doxorubicin—breast cancer	4.31e-05	0.000222	CcSEcCtD
Ranolazine—Decreased appetite—Methotrexate—breast cancer	4.29e-05	0.000221	CcSEcCtD
Ranolazine—Headache—Docetaxel—breast cancer	4.29e-05	0.000221	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Methotrexate—breast cancer	4.26e-05	0.000219	CcSEcCtD
Ranolazine—Fatigue—Methotrexate—breast cancer	4.26e-05	0.000219	CcSEcCtD
Ranolazine—Vomiting—Capecitabine—breast cancer	4.22e-05	0.000217	CcSEcCtD
Ranolazine—Shock—Doxorubicin—breast cancer	4.21e-05	0.000216	CcSEcCtD
Ranolazine—Nervous system disorder—Doxorubicin—breast cancer	4.19e-05	0.000216	CcSEcCtD
Ranolazine—Thrombocytopenia—Doxorubicin—breast cancer	4.19e-05	0.000215	CcSEcCtD
Ranolazine—Rash—Capecitabine—breast cancer	4.18e-05	0.000215	CcSEcCtD
Ranolazine—Insomnia—Epirubicin—breast cancer	4.18e-05	0.000215	CcSEcCtD
Ranolazine—Dermatitis—Capecitabine—breast cancer	4.18e-05	0.000215	CcSEcCtD
Ranolazine—Headache—Capecitabine—breast cancer	4.16e-05	0.000214	CcSEcCtD
Ranolazine—Skin disorder—Doxorubicin—breast cancer	4.15e-05	0.000214	CcSEcCtD
Ranolazine—Paraesthesia—Epirubicin—breast cancer	4.15e-05	0.000214	CcSEcCtD
Ranolazine—Hyperhidrosis—Doxorubicin—breast cancer	4.13e-05	0.000213	CcSEcCtD
Ranolazine—Dyspnoea—Epirubicin—breast cancer	4.12e-05	0.000212	CcSEcCtD
Ranolazine—Somnolence—Epirubicin—breast cancer	4.11e-05	0.000211	CcSEcCtD
Ranolazine—Anorexia—Doxorubicin—breast cancer	4.08e-05	0.00021	CcSEcCtD
Ranolazine—Nausea—Docetaxel—breast cancer	4.07e-05	0.000209	CcSEcCtD
Ranolazine—Feeling abnormal—Methotrexate—breast cancer	4.07e-05	0.000209	CcSEcCtD
Ranolazine—Dyspepsia—Epirubicin—breast cancer	4.07e-05	0.000209	CcSEcCtD
Ranolazine—Gastrointestinal pain—Methotrexate—breast cancer	4.04e-05	0.000208	CcSEcCtD
Ranolazine—Decreased appetite—Epirubicin—breast cancer	4.02e-05	0.000207	CcSEcCtD
Ranolazine—Hypotension—Doxorubicin—breast cancer	4e-05	0.000206	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Epirubicin—breast cancer	3.99e-05	0.000205	CcSEcCtD
Ranolazine—Fatigue—Epirubicin—breast cancer	3.98e-05	0.000205	CcSEcCtD
Ranolazine—Constipation—Epirubicin—breast cancer	3.95e-05	0.000203	CcSEcCtD
Ranolazine—Nausea—Capecitabine—breast cancer	3.94e-05	0.000203	CcSEcCtD
Ranolazine—Urticaria—Methotrexate—breast cancer	3.92e-05	0.000202	CcSEcCtD
Ranolazine—Abdominal pain—Methotrexate—breast cancer	3.9e-05	0.000201	CcSEcCtD
Ranolazine—Insomnia—Doxorubicin—breast cancer	3.87e-05	0.000199	CcSEcCtD
Ranolazine—Paraesthesia—Doxorubicin—breast cancer	3.84e-05	0.000198	CcSEcCtD
Ranolazine—Dyspnoea—Doxorubicin—breast cancer	3.81e-05	0.000196	CcSEcCtD
Ranolazine—Feeling abnormal—Epirubicin—breast cancer	3.81e-05	0.000196	CcSEcCtD
Ranolazine—Somnolence—Doxorubicin—breast cancer	3.8e-05	0.000196	CcSEcCtD
Ranolazine—Gastrointestinal pain—Epirubicin—breast cancer	3.78e-05	0.000194	CcSEcCtD
Ranolazine—Dyspepsia—Doxorubicin—breast cancer	3.76e-05	0.000194	CcSEcCtD
Ranolazine—Decreased appetite—Doxorubicin—breast cancer	3.72e-05	0.000191	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Doxorubicin—breast cancer	3.69e-05	0.00019	CcSEcCtD
Ranolazine—Fatigue—Doxorubicin—breast cancer	3.69e-05	0.00019	CcSEcCtD
Ranolazine—Urticaria—Epirubicin—breast cancer	3.67e-05	0.000189	CcSEcCtD
Ranolazine—Constipation—Doxorubicin—breast cancer	3.66e-05	0.000188	CcSEcCtD
Ranolazine—Abdominal pain—Epirubicin—breast cancer	3.65e-05	0.000188	CcSEcCtD
Ranolazine—Asthenia—Methotrexate—breast cancer	3.54e-05	0.000182	CcSEcCtD
Ranolazine—Feeling abnormal—Doxorubicin—breast cancer	3.52e-05	0.000181	CcSEcCtD
Ranolazine—Gastrointestinal pain—Doxorubicin—breast cancer	3.5e-05	0.00018	CcSEcCtD
Ranolazine—Pruritus—Methotrexate—breast cancer	3.49e-05	0.00018	CcSEcCtD
Ranolazine—Urticaria—Doxorubicin—breast cancer	3.4e-05	0.000175	CcSEcCtD
Ranolazine—Abdominal pain—Doxorubicin—breast cancer	3.38e-05	0.000174	CcSEcCtD
Ranolazine—Asthenia—Epirubicin—breast cancer	3.32e-05	0.000171	CcSEcCtD
Ranolazine—Pruritus—Epirubicin—breast cancer	3.27e-05	0.000168	CcSEcCtD
Ranolazine—Dizziness—Methotrexate—breast cancer	3.27e-05	0.000168	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—CTNNB1—breast cancer	3.23e-05	0.000629	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—ERBB2—breast cancer	3.22e-05	0.000628	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—KDR—breast cancer	3.21e-05	0.000626	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	3.17e-05	0.000618	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MMP9—breast cancer	3.16e-05	0.000617	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—COMT—breast cancer	3.15e-05	0.000615	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MET—breast cancer	3.14e-05	0.000613	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CDK4—breast cancer	3.14e-05	0.000613	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GSTP1—breast cancer	3.14e-05	0.000613	CbGpPWpGaD
Ranolazine—Vomiting—Methotrexate—breast cancer	3.14e-05	0.000162	CcSEcCtD
Ranolazine—CYP3A4—Biological oxidations—MTR—breast cancer	3.11e-05	0.000607	CbGpPWpGaD
Ranolazine—Rash—Methotrexate—breast cancer	3.11e-05	0.00016	CcSEcCtD
Ranolazine—CYP2D6—Metapathway biotransformation—COMT—breast cancer	3.11e-05	0.000607	CbGpPWpGaD
Ranolazine—Dermatitis—Methotrexate—breast cancer	3.11e-05	0.00016	CcSEcCtD
Ranolazine—CYP2D6—Metapathway biotransformation—GSTP1—breast cancer	3.1e-05	0.000604	CbGpPWpGaD
Ranolazine—Headache—Methotrexate—breast cancer	3.09e-05	0.000159	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL6—breast cancer	3.08e-05	0.0006	CbGpPWpGaD
Ranolazine—Asthenia—Doxorubicin—breast cancer	3.07e-05	0.000158	CcSEcCtD
Ranolazine—Dizziness—Epirubicin—breast cancer	3.06e-05	0.000157	CcSEcCtD
Ranolazine—CYP3A4—Biological oxidations—HPGDS—breast cancer	3.05e-05	0.000596	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—NOTCH1—breast cancer	3.02e-05	0.00059	CbGpPWpGaD
Ranolazine—Pruritus—Doxorubicin—breast cancer	3.02e-05	0.000156	CcSEcCtD
Ranolazine—CYP3A4—Biological oxidations—GSTT1—breast cancer	2.96e-05	0.000578	CbGpPWpGaD
Ranolazine—Vomiting—Epirubicin—breast cancer	2.94e-05	0.000151	CcSEcCtD
Ranolazine—Nausea—Methotrexate—breast cancer	2.93e-05	0.000151	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—SRC—breast cancer	2.92e-05	0.000569	CbGpPWpGaD
Ranolazine—Rash—Epirubicin—breast cancer	2.91e-05	0.00015	CcSEcCtD
Ranolazine—Dermatitis—Epirubicin—breast cancer	2.91e-05	0.00015	CcSEcCtD
Ranolazine—Headache—Epirubicin—breast cancer	2.89e-05	0.000149	CcSEcCtD
Ranolazine—CYP2D6—Biological oxidations—GSTM1—breast cancer	2.89e-05	0.000563	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—HRAS—breast cancer	2.88e-05	0.000561	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—GSTM1—breast cancer	2.85e-05	0.000555	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—VEGFA—breast cancer	2.84e-05	0.000554	CbGpPWpGaD
Ranolazine—Dizziness—Doxorubicin—breast cancer	2.83e-05	0.000146	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—STAT3—breast cancer	2.81e-05	0.000549	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP17A1—breast cancer	2.8e-05	0.000547	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—PTGS1—breast cancer	2.78e-05	0.000541	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	2.76e-05	0.000539	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MMP9—breast cancer	2.76e-05	0.000539	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—IL6—breast cancer	2.75e-05	0.000537	CbGpPWpGaD
Ranolazine—Nausea—Epirubicin—breast cancer	2.74e-05	0.000141	CcSEcCtD
Ranolazine—CYP2D6—Biological oxidations—CYP1A1—breast cancer	2.74e-05	0.000534	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP2D6—breast cancer	2.72e-05	0.000531	CbGpPWpGaD
Ranolazine—Vomiting—Doxorubicin—breast cancer	2.72e-05	0.00014	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—AKT2—breast cancer	2.71e-05	0.000528	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP1A1—breast cancer	2.7e-05	0.000526	CbGpPWpGaD
Ranolazine—Rash—Doxorubicin—breast cancer	2.7e-05	0.000139	CcSEcCtD
Ranolazine—Dermatitis—Doxorubicin—breast cancer	2.69e-05	0.000139	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—MAPK3—breast cancer	2.69e-05	0.000524	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	2.68e-05	0.000524	CbGpPWpGaD
Ranolazine—Headache—Doxorubicin—breast cancer	2.68e-05	0.000138	CcSEcCtD
Ranolazine—CYP3A4—Biological oxidations—NCOA2—breast cancer	2.67e-05	0.000521	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MMP2—breast cancer	2.62e-05	0.000511	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TGFB1—breast cancer	2.61e-05	0.000508	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—EGFR—breast cancer	2.56e-05	0.000499	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—SRC—breast cancer	2.55e-05	0.000497	CbGpPWpGaD
Ranolazine—Nausea—Doxorubicin—breast cancer	2.54e-05	0.000131	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—VEGFA—breast cancer	2.48e-05	0.000484	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TNF—breast cancer	2.43e-05	0.000475	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—KRAS—breast cancer	2.41e-05	0.000471	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP1B1—breast cancer	2.36e-05	0.00046	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MAPK3—breast cancer	2.35e-05	0.000458	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	2.33e-05	0.000454	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—RAF1—breast cancer	2.32e-05	0.000453	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—RELA—breast cancer	2.31e-05	0.000451	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—ERBB2—breast cancer	2.3e-05	0.000448	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—NCOA1—breast cancer	2.25e-05	0.000439	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—EGFR—breast cancer	2.23e-05	0.000435	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP19A1—breast cancer	2.22e-05	0.000433	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SYNJ2—breast cancer	2.2e-05	0.000429	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	2.19e-05	0.000427	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—KRAS—breast cancer	2.11e-05	0.000411	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—COMT—breast cancer	2.06e-05	0.000402	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTP1—breast cancer	2.05e-05	0.0004	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—HRAS—breast cancer	2.05e-05	0.0004	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NDUFS3—breast cancer	2.05e-05	0.000399	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—COMT—breast cancer	2.03e-05	0.000397	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	2.02e-05	0.000395	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CTNNB1—breast cancer	2.01e-05	0.000392	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MMP9—breast cancer	1.97e-05	0.000384	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—IL6—breast cancer	1.96e-05	0.000383	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CHST9—breast cancer	1.92e-05	0.000375	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTM1—breast cancer	1.89e-05	0.000368	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	1.86e-05	0.000363	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—COX11—breast cancer	1.82e-05	0.000356	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—SRC—breast cancer	1.82e-05	0.000354	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—AKT1—breast cancer	1.81e-05	0.000353	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—HRAS—breast cancer	1.79e-05	0.000349	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP1A1—breast cancer	1.79e-05	0.000349	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—VEGFA—breast cancer	1.77e-05	0.000345	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.76e-05	0.000344	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—STAT3—breast cancer	1.75e-05	0.000342	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—IL6—breast cancer	1.71e-05	0.000335	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MAPK3—breast cancer	1.67e-05	0.000326	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CDA—breast cancer	1.67e-05	0.000325	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SHMT1—breast cancer	1.67e-05	0.000325	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TGFB1—breast cancer	1.62e-05	0.000317	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SLCO1B1—breast cancer	1.61e-05	0.000313	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SLC2A5—breast cancer	1.61e-05	0.000313	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—EGFR—breast cancer	1.59e-05	0.000311	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—APRT—breast cancer	1.55e-05	0.000302	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TNF—breast cancer	1.52e-05	0.000296	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—KRAS—breast cancer	1.5e-05	0.000293	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ESRRA—breast cancer	1.46e-05	0.000284	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ANGPTL4—breast cancer	1.46e-05	0.000284	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SYNJ2—breast cancer	1.44e-05	0.000281	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HADHB—breast cancer	1.38e-05	0.00027	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GPI—breast cancer	1.38e-05	0.00027	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NDUFS3—breast cancer	1.34e-05	0.000261	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALDH7A1—breast cancer	1.32e-05	0.000257	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALDH1A1—breast cancer	1.32e-05	0.000257	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—HRAS—breast cancer	1.28e-05	0.000249	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—FHL2—breast cancer	1.26e-05	0.000247	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NME1—breast cancer	1.26e-05	0.000247	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PHGDH—breast cancer	1.26e-05	0.000247	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ADSL—breast cancer	1.26e-05	0.000247	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—UMPS—breast cancer	1.26e-05	0.000247	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CHST9—breast cancer	1.26e-05	0.000245	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—LDHB—breast cancer	1.24e-05	0.000242	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—BRIP1—breast cancer	1.24e-05	0.000242	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HPSE—breast cancer	1.24e-05	0.000242	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—IL6—breast cancer	1.22e-05	0.000239	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—COX11—breast cancer	1.19e-05	0.000233	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTA3—breast cancer	1.17e-05	0.000229	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HMMR—breast cancer	1.17e-05	0.000229	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ABCC1—breast cancer	1.17e-05	0.000229	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PPARGC1B—breast cancer	1.14e-05	0.000222	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—AKT1—breast cancer	1.13e-05	0.00022	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CDA—breast cancer	1.09e-05	0.000213	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SHMT1—breast cancer	1.09e-05	0.000213	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTA4—breast cancer	1.07e-05	0.00021	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CA9—breast cancer	1.07e-05	0.00021	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SLC2A5—breast cancer	1.05e-05	0.000205	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.05e-05	0.000205	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTA2—breast cancer	1.05e-05	0.000204	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GPX2—breast cancer	1.05e-05	0.000204	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GPX4—breast cancer	1.03e-05	0.000202	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SULT1A1—breast cancer	1.03e-05	0.000202	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—APRT—breast cancer	1.01e-05	0.000198	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTA1—breast cancer	1.01e-05	0.000197	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—IDH1—breast cancer	1.01e-05	0.000197	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NAT2—breast cancer	9.99e-06	0.000195	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ESRRA—breast cancer	9.53e-06	0.000186	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ANGPTL4—breast cancer	9.53e-06	0.000186	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GPI—breast cancer	9.03e-06	0.000176	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HADHB—breast cancer	9.03e-06	0.000176	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MED12—breast cancer	8.76e-06	0.000171	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—DPYD—breast cancer	8.76e-06	0.000171	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALDOA—breast cancer	8.62e-06	0.000168	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALDH7A1—breast cancer	8.62e-06	0.000168	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALDH1A1—breast cancer	8.62e-06	0.000168	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NCOA3—breast cancer	8.37e-06	0.000163	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SLC2A2—breast cancer	8.31e-06	0.000162	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ADSL—breast cancer	8.26e-06	0.000161	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—FHL2—breast cancer	8.26e-06	0.000161	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PHGDH—breast cancer	8.26e-06	0.000161	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—UMPS—breast cancer	8.26e-06	0.000161	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NME1—breast cancer	8.26e-06	0.000161	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ABCG2—breast cancer	8.14e-06	0.000159	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CPT1A—breast cancer	8.14e-06	0.000159	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MTR—breast cancer	8.14e-06	0.000159	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—LDHB—breast cancer	8.1e-06	0.000158	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—BRIP1—breast cancer	8.1e-06	0.000158	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HPSE—breast cancer	8.1e-06	0.000158	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HPGDS—breast cancer	7.99e-06	0.000156	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HBA1—breast cancer	7.94e-06	0.000155	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ACHE—breast cancer	7.75e-06	0.000151	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTT1—breast cancer	7.75e-06	0.000151	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ABCC1—breast cancer	7.68e-06	0.00015	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HMMR—breast cancer	7.68e-06	0.00015	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTA3—breast cancer	7.68e-06	0.00015	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PPARGC1B—breast cancer	7.44e-06	0.000145	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP17A1—breast cancer	7.33e-06	0.000143	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ENO1—breast cancer	7.26e-06	0.000142	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PTGS1—breast cancer	7.26e-06	0.000142	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CA9—breast cancer	7.03e-06	0.000137	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTA4—breast cancer	7.03e-06	0.000137	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NCOA2—breast cancer	6.99e-06	0.000136	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTA2—breast cancer	6.85e-06	0.000134	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GPX2—breast cancer	6.85e-06	0.000134	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—FASN—breast cancer	6.78e-06	0.000132	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SULT1A1—breast cancer	6.76e-06	0.000132	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GPX4—breast cancer	6.76e-06	0.000132	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—BCHE—breast cancer	6.75e-06	0.000132	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SLC5A5—breast cancer	6.67e-06	0.00013	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTA1—breast cancer	6.61e-06	0.000129	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—IDH1—breast cancer	6.61e-06	0.000129	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NAT2—breast cancer	6.53e-06	0.000127	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NQO1—breast cancer	6.44e-06	0.000126	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SLC2A1—breast cancer	6.44e-06	0.000126	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP3A4—breast cancer	6.28e-06	0.000122	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP1B1—breast cancer	6.17e-06	0.00012	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HSP90AA1—breast cancer	6.05e-06	0.000118	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NCOA1—breast cancer	5.89e-06	0.000115	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP19A1—breast cancer	5.8e-06	0.000113	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—STK11—breast cancer	5.8e-06	0.000113	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—DPYD—breast cancer	5.73e-06	0.000112	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MED12—breast cancer	5.73e-06	0.000112	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALDOA—breast cancer	5.64e-06	0.00011	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NCOA3—breast cancer	5.47e-06	0.000107	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SLC2A2—breast cancer	5.44e-06	0.000106	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—COMT—breast cancer	5.4e-06	0.000105	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTP1—breast cancer	5.37e-06	0.000105	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MTR—breast cancer	5.32e-06	0.000104	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CPT1A—breast cancer	5.32e-06	0.000104	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ABCG2—breast cancer	5.32e-06	0.000104	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HMOX1—breast cancer	5.3e-06	0.000103	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ITPR1—breast cancer	5.28e-06	0.000103	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HPGDS—breast cancer	5.22e-06	0.000102	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HBA1—breast cancer	5.19e-06	0.000101	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ABCB1—breast cancer	5.08e-06	9.92e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTT1—breast cancer	5.06e-06	9.88e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ACHE—breast cancer	5.06e-06	9.88e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—TYMS—breast cancer	4.99e-06	9.74e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PLA2G4A—breast cancer	4.93e-06	9.63e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NCOR1—breast cancer	4.93e-06	9.63e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTM1—breast cancer	4.93e-06	9.63e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP17A1—breast cancer	4.79e-06	9.35e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ENO1—breast cancer	4.75e-06	9.26e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PTGS1—breast cancer	4.75e-06	9.26e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GPX1—breast cancer	4.73e-06	9.22e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP1A1—breast cancer	4.68e-06	9.13e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP2D6—breast cancer	4.65e-06	9.08e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ERCC2—breast cancer	4.64e-06	9.05e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NCOA2—breast cancer	4.57e-06	8.91e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—FASN—breast cancer	4.43e-06	8.64e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—BCHE—breast cancer	4.41e-06	8.61e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MTHFR—breast cancer	4.36e-06	8.51e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SLC5A5—breast cancer	4.36e-06	8.5e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NQO1—breast cancer	4.21e-06	8.21e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SLC2A1—breast cancer	4.21e-06	8.21e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP1B1—breast cancer	4.04e-06	7.87e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CAV1—breast cancer	4.02e-06	7.85e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.96e-06	7.72e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NCOA1—breast cancer	3.85e-06	7.51e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—STK11—breast cancer	3.79e-06	7.4e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP19A1—breast cancer	3.79e-06	7.4e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CG—breast cancer	3.66e-06	7.15e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—COMT—breast cancer	3.53e-06	6.88e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTP1—breast cancer	3.51e-06	6.85e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HMOX1—breast cancer	3.46e-06	6.75e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ITPR1—breast cancer	3.45e-06	6.74e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ABCB1—breast cancer	3.32e-06	6.48e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—TYMS—breast cancer	3.26e-06	6.37e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NCOR1—breast cancer	3.23e-06	6.29e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.23e-06	6.29e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTM1—breast cancer	3.23e-06	6.29e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CD—breast cancer	3.22e-06	6.28e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALB—breast cancer	3.18e-06	6.2e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GPX1—breast cancer	3.09e-06	6.03e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP1A1—breast cancer	3.06e-06	5.97e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NOS3—breast cancer	3.04e-06	5.93e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ERCC2—breast cancer	3.03e-06	5.92e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MTHFR—breast cancer	2.85e-06	5.56e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CB—breast cancer	2.81e-06	5.48e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PTGS2—breast cancer	2.78e-06	5.43e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CAV1—breast cancer	2.63e-06	5.13e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PTEN—breast cancer	2.43e-06	4.73e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CG—breast cancer	2.4e-06	4.67e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CD—breast cancer	2.11e-06	4.11e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALB—breast cancer	2.08e-06	4.06e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NOS3—breast cancer	1.99e-06	3.88e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.84e-06	3.58e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PTGS2—breast cancer	1.82e-06	3.55e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.71e-06	3.34e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PTEN—breast cancer	1.59e-06	3.09e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AKT1—breast cancer	1.4e-06	2.73e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CA—breast cancer	1.12e-06	2.18e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AKT1—breast cancer	9.14e-07	1.78e-05	CbGpPWpGaD
